300765 新诺威
已收盘 04-13 15:00:00
资讯
新帖
简况
股市必读：新诺威（300765）4月7日董秘有最新回复
证券之星 · 04-08
股市必读：新诺威（300765）4月7日董秘有最新回复
新诺威：截至2026年3月31日，公司合并普通账户和融资融券信用账户股东数为24,034户
证券之星 · 04-07
新诺威：截至2026年3月31日，公司合并普通账户和融资融券信用账户股东数为24,034户
新诺威（300765）披露2025年度网上业绩说明会公告，4月03日股价下跌3.47%
证券之星 · 04-03
新诺威（300765）披露2025年度网上业绩说明会公告，4月03日股价下跌3.47%
4月1日新诺威涨8.47%，工银前沿医疗股票A基金重仓该股
证券之星 · 04-01
4月1日新诺威涨8.47%，工银前沿医疗股票A基金重仓该股
股市必读：新诺威（300765）3月27日董秘有最新回复
证券之星 · 03-30
股市必读：新诺威（300765）3月27日董秘有最新回复
新诺威：截至2026年3月20日股东数为21,269户
证券之星 · 03-28
新诺威：截至2026年3月20日股东数为21,269户
3月26日新诺威跌5.09%，工银前沿医疗股票A基金重仓该股
证券之星 · 03-26
3月26日新诺威跌5.09%，工银前沿医疗股票A基金重仓该股
股市必读：新诺威（300765）今年截至3月23日累计跌幅已超20%
证券之星 · 03-24
股市必读：新诺威（300765）今年截至3月23日累计跌幅已超20%
股市必读：新诺威（300765）3月18日披露最新机构调研信息
证券之星 · 03-19
股市必读：新诺威（300765）3月18日披露最新机构调研信息
新诺威：3月17日接受机构调研，包括知名机构淡水泉，高毅资产的多家机构参与
证券之星 · 03-18
新诺威：3月17日接受机构调研，包括知名机构淡水泉，高毅资产的多家机构参与
新诺威最新公告：2025年亏损2.41亿元同比由盈转亏
证券之星 · 03-16
新诺威最新公告：2025年亏损2.41亿元同比由盈转亏
3月16日新诺威涨6.70%，工银前沿医疗股票A基金重仓该股
证券之星 · 03-16
3月16日新诺威涨6.70%，工银前沿医疗股票A基金重仓该股
新诺威（300765）披露使用部分闲置募集资金进行现金管理的进展公告，3月13日股价下跌1.74%
证券之星 · 03-13
新诺威（300765）披露使用部分闲置募集资金进行现金管理的进展公告，3月13日股价下跌1.74%
股市必读：3月10日新诺威现1233.98万元大宗交易
证券之星 · 03-11
股市必读：3月10日新诺威现1233.98万元大宗交易
新诺威：截至2026年2月27日股东数为19,761户
证券之星 · 03-05
新诺威：截至2026年2月27日股东数为19,761户
新诺威(300765.SZ)：艾美赛珠单抗注射液获准开展临试
智通财经 · 03-04
新诺威(300765.SZ)：艾美赛珠单抗注射液获准开展临试
3月2日新诺威发生2笔大宗交易 成交金额598.48万元
证券之星 · 03-02
3月2日新诺威发生2笔大宗交易 成交金额598.48万元
新诺威（300765）披露转让参股公司股份暨关联交易公告，2月26日股价下跌2.72%
证券之星 · 02-26
新诺威（300765）披露转让参股公司股份暨关联交易公告，2月26日股价下跌2.72%
新诺威最新公告：拟2.3亿元转让国新汇金30%股份给石药控股
证券之星 · 02-26
新诺威最新公告：拟2.3亿元转让国新汇金30%股份给石药控股
新诺威（300765）披露控股子公司及关联方与阿斯利康签署战略合作与授权协议暨关联交易议案获通过，2月24日股价下跌0.42%
证券之星 · 02-24
新诺威（300765）披露控股子公司及关联方与阿斯利康签署战略合作与授权协议暨关联交易议案获通过，2月24日股价下跌0.42%
加载更多
公司概况
公司名称：
石药创新制药股份有限公司
所属行业：
食品制造业
上市日期：
2019-03-22
主营业务：
石药创新制药股份有限公司的主营业务是生物制药、功能性原料及保健食品的研发、生产与商业化。公司的主要产品是恩朗苏拜单抗注射液、注射用奥马珠单抗注射液、咖啡因、阿卡波糖、果维康维生素C咀嚼片。公司是国内首批实现mRNA疫苗产业化、ADC与抗体药物管线布局最完整的创新型生物药企业之一，已发展成为集源头创新、临床转化、规模生产与国际商业化于一体的高新技术企业。
发行价格：
24.47
{"stockData":{"symbol":"300765","market":"SZ","secType":"STK","nameCN":"新诺威","latestPrice":33.09,"timestamp":1776063828000,"preClose":32.6,"halted":0,"volume":10302876,"delay":0,"changeRate":0.015,"floatShares":1405000000,"shares":1405000000,"eps":-0.3816,"marketStatus":"已收盘","change":0.49,"latestTime":"04-13 15:00:00","open":32.38,"high":34.17,"low":32.2,"amount":344000000,"amplitude":0.0604,"askPrice":33.1,"askSize":10,"bidPrice":33.09,"bidSize":63,"shortable":0,"etf":0,"ttmEps":-0.3816,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776130200000},"marketStatusCode":5,"adr":0,"adjPreClose":32.6,"symbolType":"stock","openAndCloseTimeList":[[1776043800000,1776051000000],[1776056400000,1776063600000]],"highLimit":35.86,"lowLimit":29.34,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1404592944,"isCdr":false,"pbRate":17.17,"roa":"--","roe":"--","epsLYR":-0.1731,"committee":0.818182,"marketValue":46478000000,"turnoverRate":0.0073,"status":0,"floatMarketCap":46478000000},"requestUrl":"/m/hq/s/300765","defaultTab":"news","newsList":[{"id":"2625950316","title":"股市必读：新诺威（300765）4月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625950316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625950316?lang=zh_cn&edition=full","pubTime":"2026-04-08 01:28","pubTimestamp":1775582893,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，新诺威报收于33.25元，上涨2.28%，换手率0.77%，成交量10.84万手，成交额3.61亿元。董秘最新回复投资者： 请问贵公司截至2026年3月30日收盘的股东的户数？董秘： 您好，感谢您对公司的关注，截至2026年3月31日，公司合并普通账户和融资融券信用账户股东数为24,034户，谢谢！当日关注点来自交易信息汇总：4月7日主力资金净流出274.03万元，游资资金净流入3492.0万元，显示市场短期交易情绪分化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800000930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625818930","title":"新诺威：截至2026年3月31日，公司合并普通账户和融资融券信用账户股东数为24,034户","url":"https://stock-news.laohu8.com/highlight/detail?id=2625818930","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625818930?lang=zh_cn&edition=full","pubTime":"2026-04-07 19:54","pubTimestamp":1775562851,"startTime":"0","endTime":"0","summary":"证券之星消息，新诺威(300765)04月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年3月31日，公司最新股东数是多少？新诺威回复：您好，感谢您对公司的关注，截至2026年3月31日，公司合并普通账户和融资融券信用账户股东数为24,034户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700028419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624253659","title":"新诺威（300765）披露2025年度网上业绩说明会公告，4月03日股价下跌3.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624253659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624253659?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:45","pubTimestamp":1775209521,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，新诺威报收于32.51元，较前一交易日下跌3.47%，最新总市值为456.63亿元。该股当日开盘33.11元，最高33.52元，最低32.38元，成交额达3.44亿元，换手率为0.75%。公司于近日披露《关于举行2025年度网上业绩说明会的公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624595369","title":"4月1日新诺威涨8.47%，工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624595369","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624595369?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:18","pubTimestamp":1775031483,"startTime":"0","endTime":"0","summary":"证券之星消息，4月1日新诺威涨8.47%，收盘报34.45元，换手率1.62%，成交量22.75万手，成交额7.68亿元。重仓新诺威的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共38家，其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100029144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","159891","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623956352","title":"股市必读：新诺威（300765）3月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2623956352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623956352?lang=zh_cn&edition=full","pubTime":"2026-03-30 01:00","pubTimestamp":1774803643,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，新诺威报收于32.28元，上涨14.63%，换手率1.64%，成交量23.06万手，成交额7.14亿元。董秘最新回复投资者： 请问截止3月10日公司股东人数是多少？董秘： 您好，感谢您对公司的关注，截至2026年3月20日，公司合并普通账户和融资融券信用账户股东数为21,269户，谢谢！当日关注点来自交易信息汇总：3月27日主力资金净流入5580.28万元，呈现明显吸筹迹象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622802410","title":"新诺威：截至2026年3月20日股东数为21,269户","url":"https://stock-news.laohu8.com/highlight/detail?id=2622802410","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622802410?lang=zh_cn&edition=full","pubTime":"2026-03-28 10:48","pubTimestamp":1774666089,"startTime":"0","endTime":"0","summary":"证券之星消息，新诺威(300765)03月28日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好。请问贵公司截至2026年3月20日收盘的股东人数是多少？新诺威回复：您好，感谢您对公司的关注，截至2026年3月20日，公司合并普通账户和融资融券信用账户股东数为21,269户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800013874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622837941","title":"3月26日新诺威跌5.09%，工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622837941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622837941?lang=zh_cn&edition=full","pubTime":"2026-03-26 16:27","pubTimestamp":1774513665,"startTime":"0","endTime":"0","summary":"证券之星消息，3月26日新诺威跌5.09%，收盘报28.16元，换手率0.86%，成交量12.07万手，成交额3.47亿元。重仓新诺威的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共38家，其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600029066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621085982","title":"股市必读：新诺威（300765）今年截至3月23日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621085982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621085982?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:02","pubTimestamp":1774288941,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，新诺威报收于28.0元，下跌7.16%，换手率0.85%，成交量11.91万手，成交额3.43亿元。来自资金流向：3月23日主力资金净流出1454.49万元，散户资金净流入4562.21万元，呈现主力抛售、散户接盘态势。交易信息汇总股价提醒3月23日新诺威收盘报28元，跌7.16%，当日成交1190.93万元。该股已连续4日下跌，当年累计跌幅22.16%。前10个交易日资金流向显示：主力资金累计净流出2351.35万元，股价累计下跌9.22%；融资余额累计增加1188.84万元，融券余量累计增加4.34万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620266746","title":"股市必读：新诺威（300765）3月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2620266746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620266746?lang=zh_cn&edition=full","pubTime":"2026-03-19 02:18","pubTimestamp":1773857893,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘，新诺威报收于32.05元，下跌0.93%，换手率0.54%，成交量7.56万手，成交额2.42亿元。当日关注点来自交易信息汇总：3月18日主力资金净流出153.66万元，散户资金净流入235.38万元。另外国内正在进行的 EGFR突变型肺癌3期临床试验已经完成入组，目前正在受试者随访中。的首个完整销售年度，公司生物制药业务收入实现显著增长。2026年，随着销售团队的持续扩充及市场推广力度的加大，公司看好生物制药业务的发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900001196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620528807","title":"新诺威：3月17日接受机构调研，包括知名机构淡水泉，高毅资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2620528807","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620528807?lang=zh_cn&edition=full","pubTime":"2026-03-18 10:30","pubTimestamp":1773801034,"startTime":"0","endTime":"0","summary":"2026年以来，咖啡因价格趋于稳定，后续公司会持续关注咖啡因的价格走势。除上述临床外，公司也在积极推进食管鳞癌，乳腺癌等适应症。的首个完整销售年度，公司生物制药业务收入实现显著增长。2026年，随着销售团队的持续扩充及市场推广力度的加大，公司看好生物制药业务的发展。新诺威主营业务：生物制药和功能食品及原料的研发、生产和销售。该股最近90天内共有1家机构给出评级，买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800013153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619450921","title":"新诺威最新公告：2025年亏损2.41亿元同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2619450921","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619450921?lang=zh_cn&edition=full","pubTime":"2026-03-16 19:40","pubTimestamp":1773661237,"startTime":"0","endTime":"0","summary":"新诺威发布2025年年度报告，2025年公司实现营业收入为21.58亿元，同比增长8.93%，归属于上市公司股东的净利润-2.41亿元，同比由盈转亏；基本每股收益-0.1731元。2025年公司投入研发费用10.36亿元，同比增长23.01%。公司在研项目众多，截至2025年末，公司拥有十余款处于临床或后期开发阶段的主要在研药物，其中乌司奴单抗注射液、帕妥珠单抗注射液已递交上市申请，多个项目处于关键临床试验阶段，这些研发成果将有望成为公司未来业绩增长的驱动引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600030714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619453530","title":"3月16日新诺威涨6.70%，工银前沿医疗股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619453530","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619453530?lang=zh_cn&edition=full","pubTime":"2026-03-16 16:27","pubTimestamp":1773649673,"startTime":"0","endTime":"0","summary":"证券之星消息，3月16日新诺威涨6.70%，收盘报32.0元，换手率1.0%，成交量14.03万手，成交额4.43亿元。重仓新诺威的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共38家，其中持有数量最多的公募基金为工银瑞信基金的工银前沿医疗股票A。该公募基金现任基金经理为赵蓓。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600021717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619115965","title":"新诺威（300765）披露使用部分闲置募集资金进行现金管理的进展公告，3月13日股价下跌1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619115965","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619115965?lang=zh_cn&edition=full","pubTime":"2026-03-13 22:34","pubTimestamp":1773412461,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，新诺威报收于29.99元，较前一交易日下跌1.74%，最新总市值为421.24亿元。该股当日开盘30.48元，最高30.66元，最低29.76元，成交额达1.83亿元，换手率为0.43%。新诺威于近日披露《关于使用部分闲置募集资金进行现金管理的进展公告》。公告显示，公司及子公司使用不超过8.00亿元的闲置募集资金进行现金管理，投资安全性高、流动性好的保本型产品。上述现金管理事项在股东大会授权范围内，无需另行审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300041799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618237950","title":"股市必读：3月10日新诺威现1233.98万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2618237950","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618237950?lang=zh_cn&edition=full","pubTime":"2026-03-11 01:33","pubTimestamp":1773163990,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，新诺威报收于31.82元，上涨3.11%，换手率0.75%，成交量10.47万手，成交额3.34亿元。来自交易信息汇总：同日游资资金净流入1011.82万元，反映短线交易热度上升。来自交易信息汇总：新诺威当日发生1233.98万元大宗交易，可能暗示机构间仓位调整。交易信息汇总资金流向3月10日主力资金净流出738.79万元；游资资金净流入1011.82万元；散户资金净流出273.03万元。大宗交易3月10日新诺威现1233.98万元大宗交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100000709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617548237","title":"新诺威：截至2026年2月27日股东数为19,761户","url":"https://stock-news.laohu8.com/highlight/detail?id=2617548237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617548237?lang=zh_cn&edition=full","pubTime":"2026-03-05 18:09","pubTimestamp":1772705350,"startTime":"0","endTime":"0","summary":"证券之星消息，新诺威(300765)03月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司2月末股东人数多少？谢谢新诺威回复：您好，感谢您对公司的关注，截至2026年2月27日，公司合并普通账户和融资融券信用账户股东数为19,761户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500030928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300765","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616582488","title":"新诺威(300765.SZ)：艾美赛珠单抗注射液获准开展临试","url":"https://stock-news.laohu8.com/highlight/detail?id=2616582488","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616582488?lang=zh_cn&edition=full","pubTime":"2026-03-04 15:46","pubTimestamp":1772610394,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新诺威(300765.SZ)公告，公司控股子公司石药集团巨石生物制药有限公司(简称“巨石生物”)于近日收到国家药品监督管理局核准签发的关于艾美赛珠单抗注射液(SYS6053)的《药物临床试验批准通知书》，将于近期开展临床试验。该产品是一种修饰的人源化IgG4单克隆抗体，具有双特异性抗体结构，可桥接凝血因子IXa和凝血因子X，为原研药舒友立乐®的生物类似药，按照治疗用生物制品3.3类申报，适用于A型血友病患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新诺威(300765.SZ)：艾美赛珠单抗注射液获准开展临试","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616387869","title":"3月2日新诺威发生2笔大宗交易 成交金额598.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616387869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616387869?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:23","pubTimestamp":1772443404,"startTime":"0","endTime":"0","summary":"证券之星消息，3月2日新诺威发生大宗交易，交易数据如下：近三个月该股共发生7笔大宗交易，合计成交1.93万手。该股在过去半年内已有共计1.58亿股限售解禁股上市，占公司总股本的11.21%。截至2026年3月2日收盘，新诺威(300765)报收于31.4元，下跌4.93%，换手率0.72%，成交量10.09万手，成交额3.2亿元。该股最近90天内共有1家机构给出评级，买入评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200024840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614028282","title":"新诺威（300765）披露转让参股公司股份暨关联交易公告，2月26日股价下跌2.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614028282","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614028282?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:29","pubTimestamp":1772116154,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，新诺威报收于32.87元，较前一交易日下跌2.72%，最新总市值为461.69亿元。该股当日开盘33.7元，最高33.79元，最低32.61元，成交额达2.68亿元，换手率为0.58%。近日，新诺威披露《关于转让参股公司股份暨关联交易的公告》。公告显示，公司拟将持有的北京国新汇金股份有限公司30.0704%股份，以23,000.00万元的价格转让给关联方石药控股集团有限公司。本次交易构成关联交易，已经公司董事会及独立董事专门会议审议通过，尚需股东会批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614828019","title":"新诺威最新公告：拟2.3亿元转让国新汇金30%股份给石药控股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614828019","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614828019?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:22","pubTimestamp":1772097752,"startTime":"0","endTime":"0","summary":"新诺威(300765.SZ)公告称，公司拟将持有的国新汇金30.0704%股份以2.3亿元价格转让给石药控股，转让完成后，公司将不再持有国新汇金股份。该交易已获公司董事会通过，尚需股东会批准。交易定价参考了国融兴华资产评估有限责任公司的评估结果，增值率94.85%。所得款项将用于补充公司日常运营资金。国新汇金是以移动资讯客户端、全媒体矩阵为核心的全媒体传播业务平台。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600026468.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01093","IE00BZ08YS42.EUR","LU1226287529.USD","BK1515","BK0226","IE0008368742.USD","300765","IE00B031HY20.USD","BK1191","IE00B5MMRT66.SGD","LU0067412154.USD","LU0501845795.SGD","IE00B543WZ88.USD","LU1152091754.HKD","LU1951186391.HKD","LU1008478684.HKD","LU1226287792.SGD","LU1226288170.HKD","LU0314109678.HKD","LU0315179316.USD","HK0000165453.HKD","LU1807302812.USD","LU1328277881.USD","IE00BZ08YT58.USD","SG9999004220.SGD","LU1152091168.USD","IE00BZ08YR35.GBP","LU1993786604.SGD","IE0008369823.USD","BK1521","LU1813983027.USD","LU1226287875.USD","LU1226288253.USD","LU0880133367.SGD","LU2039709279.SGD","LU0326950275.SGD","LU1960683339.HKD","LU0072913022.USD","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613255797","title":"新诺威（300765）披露控股子公司及关联方与阿斯利康签署战略合作与授权协议暨关联交易议案获通过，2月24日股价下跌0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613255797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613255797?lang=zh_cn&edition=full","pubTime":"2026-02-24 18:48","pubTimestamp":1771930097,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，新诺威报收于33.44元，较前一交易日下跌0.42%，最新总市值为469.7亿元。新诺威于近日披露《2026年第一次临时股东会决议公告》。公告显示，石药创新制药股份有限公司于2026年2月24日召开2026年第一次临时股东会，会议审议通过了《关于控股子公司及关联方共同与阿斯利康签署战略合作与授权协议暨关联交易的议案》。出席股东共381人，代表股份116,520,295股，占公司有表决权股份总数的8.3671%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400037700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300765"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776115317115,"stockEarnings":[{"period":"1week","weight":0.0178},{"period":"1month","weight":0.1034},{"period":"3month","weight":-0.1925},{"period":"6month","weight":-0.2238},{"period":"1year","weight":-0.2025},{"period":"ytd","weight":-0.0826}],"compareEarnings":[{"period":"1week","weight":0.028},{"period":"1month","weight":-0.0261},{"period":"3month","weight":-0.0363},{"period":"6month","weight":0.0195},{"period":"1year","weight":0.2317},{"period":"ytd","weight":0.005}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"石药创新制药股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"24034人(较上一季度增加13.00%)","perCapita":"58441股","listingDate":"2019-03-22","address":"河北省石家庄市栾城区张举路62号","registeredCapital":"140459万元","survey":" 石药创新制药股份有限公司的主营业务是生物制药、功能性原料及保健食品的研发、生产与商业化。公司的主要产品是恩朗苏拜单抗注射液、注射用奥马珠单抗注射液、咖啡因、阿卡波糖、果维康维生素C咀嚼片。公司是国内首批实现mRNA疫苗产业化、ADC与抗体药物管线布局最完整的创新型生物药企业之一，已发展成为集源头创新、临床转化、规模生产与国际商业化于一体的高新技术企业。","listedPrice":24.47},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新诺威,300765,新诺威股票,新诺威股票老虎,新诺威股票老虎国际,新诺威行情,新诺威股票行情,新诺威股价,新诺威股市,新诺威股票价格,新诺威股票交易,新诺威股票购买,新诺威股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新诺威(300765)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新诺威(300765)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}